Paper · 33767635
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk.
Vázquez-Sánchez S and 6 others. Front Physiol, 2021. Cited by 54 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk. Papers, record 33767635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767635
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06668831 | Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References147
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,335,040 | Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology. | Clin J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23335040 | PubMed |
| 2 | 25,326,585 | Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. | J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/25326585 | PubMed |
| 3 | 31,063,704 | Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway. | FASEB J | 2019 | https://conductscience.org/library/papers/31063704 | PubMed |
| 4 | 1,666,263 | Excitation-contraction coupling in the heart. | Adv Exp Med Biol | 1991 | https://conductscience.org/library/papers/1666263 | PubMed |
| 5 | 17,911,404 | Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. | J Endocrinol | 2007 | https://conductscience.org/library/papers/17911404 | PubMed |
| 6 | 22,622,492 | Update on fibroblast growth factor 23 in chronic kidney disease. | Kidney Int | 2012 | https://conductscience.org/library/papers/22622492 | PubMed |
| 7 | 24,922,628 | Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study. | J Am Heart Assoc | 2014 | https://conductscience.org/library/papers/24922628 | PubMed |
| 8 | 30,042,059 | Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications. | J Diabetes Complications | 2018 | https://conductscience.org/library/papers/30042059 | PubMed |
| 9 | 31,162,838 | Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. | Int J Cancer | 2020 | https://conductscience.org/library/papers/31162838 | PubMed |
| 10 | 20,507,943 | Forging forward with 10 burning questions on FGF23 in kidney disease. | J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20507943 | PubMed |
1 to 10 of 147
See all 147 referencesCited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,793,194 | Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793194 | PubMed |
| 42,677,728 | The Binding of Fibroblast Growth Factor 23 (FGF23) to FGF Receptor-αKlotho Complex Increases Sinoatrial Electrical Activity. | Acta Physiol (Oxf) | 2026 | https://conductscience.org/library/papers/42677728 | PubMed |
| 41,987,063 | From heart to kidney: FGF23, SuPAR, and NAG as early biomarkers of cardiorenal syndrome in acute heart failure. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/41987063 | PubMed |
| 41,676,927 | Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41676927 | PubMed |
| 41,516,280 | Phosphate and Inflammation in Health and Kidney Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516280 | PubMed |
| 41,426,862 | Effects of Fibroblast Growth Factor 23 (FGF23) on the Cardiovascular System: A Review of Literature. | Cureus | 2025 | https://conductscience.org/library/papers/41426862 | PubMed |
| 40,863,356 | Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. | J Cardiovasc Dev Dis | 2025 | https://conductscience.org/library/papers/40863356 | PubMed |
| 40,741,019 | Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases. | World J Cardiol | 2025 | https://conductscience.org/library/papers/40741019 | PubMed |
| 40,612,843 | Correlation Between Fibroblast Growth Factor 23 and Biochemical Parameters in Hemodialysis Patients With End-Stage Renal Disease. | Cureus | 2025 | https://conductscience.org/library/papers/40612843 | PubMed |
| 40,438,141 | Insights into the mechanisms of angiogenesis in hepatoblastoma. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40438141 | PubMed |
1 to 10 of 45
See all 45 cited byGenes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAMK2G | 818 | PubTator's text mining | https://conductscience.org/library/genes/818 | NCBI Gene |
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FGF19 | 9,965 | PubTator's text mining | https://conductscience.org/library/genes/9965 | NCBI Gene |
| FGF23 | 8,074 | PubTator's text mining | https://conductscience.org/library/genes/8074 | NCBI Gene |
| FGFR1 | 2,260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
| FGFR4 | 2,264 | PubTator's text mining | https://conductscience.org/library/genes/2264 | NCBI Gene |
| FURIN | 5,045 | PubTator's text mining | https://conductscience.org/library/genes/5045 | NCBI Gene |
| KL | 9,365 | PubTator's text mining | https://conductscience.org/library/genes/9365 | NCBI Gene |
| NPPA | 4,878 | PubTator's text mining | https://conductscience.org/library/genes/4878 | NCBI Gene |
1 to 10 of 17
See all 17 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33767635
GET https://conductscience.org/api/papers/v1/33767635/references?page=2